Exploring
possibilities of therapeutic strategies for polyglutatamine diseases
ISN Symposium within the 46th Annual Meeting of Japanese Society for
Neurochemistry
Niigata
Convention Center, Toki Messe. Niigata City. Japan,
26 September 2003
http://brain.bri.niigata-u.ac.jp/~jsn46/
The ISN Symposium
entitled "Exploring possibilities of therapeutic strategies for polyglutatamine
diseases." was held Sep 26, 2003 at Toki Messe (Niigata Convention
Center, Niigata, Japan) in conjunction with the 46th annual meeting of
Japanese Society for Neurochemistry. The focus of this Symposium was to
explore possibilities of therapeutic strategies for polyglutamine diseases.
Speakers:
Kurt H. Fischbeck (NINCDS, NIH)
Histone deacetylase inhibitors for polyglutamine diseases.
Gen Sobue (Nagoya
Univ.)
Intervention of nuclear transport of androgen receptor.
Henry Paulson (Department
of Neurology, University of Iowa College of Medicine)
Application of RNA interference for treatment of polyglutamine diseases
Eric E. Wanker (Max
Planck Institute for Molecular Biology, Berlin, Germany)
High throughput screening for small molecules that suppress conformational
changes of polyglutamine stretches.
Dr. Kurt H. Fischbeck (NINCDS, NIH) provided an excellent review of recent
development of pathophysiologic mechanisms of polyglutamine diseases and
presented recent data on the potential application of histone deacetylase
inhibitors for polyglutamine diseases. Dr. Gen Gen Sobue (Nagoya Univ.)
presented amazing therapeutic approaches for spinal and bulbar muscular
atrophy. Based on the knowledge that nuclear transport of androgen receptor
depends on the presence of androgen, he showed endocrinological intervention
to reduce blood levels of testosterone dramatically prevented development
of neurologic phenotypes. Dr. Henry Paulson (Department of Neurology,
University of Iowa College of Medicine) discussed on the possibilities
of application of RNA interference for treatment of polyglutamine diseases.
Eric E. Wanker (Max Planck Institute for Molecular Biology, Berlin, Germany)
presented his recent progresses in the high throughput screening for molecules
with the capability of inhibiting aggregation of polyglutamine stretches.
The Symposium was
attended by 180 scientists including young investigators. The presentations
were well focused and stimulating discussions among the speakers and the
audience were made. Thus the ISN Symposium was very successful.
Shoji Tsuji
|